Summary
The method of RNA interference (RNAi) is an easy means of knocking down a gene without having to generate knockout mutants, which may prove to be difficult and time consuming. RNAi is a naturally occurring process that involves targeting the mRNA of a gene by introducing RNAs that are complementary to the target mRNA. The foreign RNAs activate an endogenous enzyme, DICER, which degrades the target mRNA. There are many ways of eliciting the RNAi response in a cell. In this chapter, we describe the use of double-stranded RNA (dsRNA) to knockdown human telomerase reverse transcriptase (hTERT), the gene that codes for the catalytic subunit of the human telomerase enzyme. dsRNA can be used to generate the RNAi response in cells of embryonic origin, such as human embryonic kidney (HEK) cells. The RNAi effect is transient because the dsRNA eventually gets degraded in the cells, and it is useful to study the short-term effects of a gene knockdown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baglioni, C., and Nilsen, T. W. (1983) Mechanisms of antiviral action of interferon. Interferon 5: 23–42.
Plasterk, R. H. (2002) RNA silencing: the genome’s immune system. Science 296: 1263–1265.
Yang, S., Tutton, S., Pierce, E., and Yoon, K. (2001) Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell. Biol. 21: 7807–7816.
Elshabir, S. M., Lendeckel, W., and Tuschl, T. (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15(2): 188–200.
Hutvágner, G., and Zamore, P. D. (2002) RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 12(2): 225–232.
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tushcl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494–498.
Snove, O., Jr., and Holen, T. (2004) Many commonly used siRNAs risk off-target activity. Biochem. Biophys. Res. Commun. 319(1): 256–263.
Karpala, A. J., Doran, T. J., and Bean, A. G. (2005) Immune responses to dsRNA: implications for gene silencing technologies. Immunol. Cell Biol. 83(3): 211–216.
Ambion (n.d.) Retrieved April 4, 2007. http://www.Ambion.com.
Shay, J. W., and Gazdar, A. F. (1997) Telomerase in the early detection of cancer. J. Clin. Pathol. 50: 106–109.
Ahmed, A., and Tollefsbol, T. O. (2003) Telomeres, telomerase and telomerase inhibition: clinical implications for cancer. J. Am. Geriatr. Soc. 51: 116–122.
Herbert, B. S., Wright, A. C., Passons, C. M. et al. (2001) Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J. Natl. Cancer Inst. 93: 39–45.
Berletch, J. B., Green, J., Cuningham, A. P., Andrews, L. G., and Tollefsbol, T. O. (2004) Novel approaches for RNA interference and their application in cancer therapy. Curr. Pharmacogenomics 2: 313–324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Lai, S.R., Andrews, L.G., Tollefsbol, T.O. (2007). hTERT Knockdown in Human Embryonic Kidney Cells Using Double-Stranded RNA. In: Andrews, L.G., Tollefsbol, T.O. (eds) Telomerase Inhibition. Methods in Molecular Biology™, vol 405. Humana Press. https://doi.org/10.1007/978-1-60327-070-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-60327-070-0_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-683-2
Online ISBN: 978-1-60327-070-0
eBook Packages: Springer Protocols